🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

57,46 USD

Máx. histórico

2.925,00

12012 días

Split 1:10 del 17/11/2011

Caída desde máximo

-98,04%

Rango 52 semanas

37,06 – 95,49

Variación hoy

-6,80%

Cierre anterior

61,65

Rango de hoy

57,24 – 61,73

Volumen hoy

1.804.873

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,85%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 11 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
28/07/2006 49,50 50,50 46,30 49,70 +1,64% 8,48% 4.710
27/07/2006 49,10 49,30 47,00 48,90 +2,52% 4,68% 5.260
26/07/2006 50,70 50,70 46,80 47,70 +4,15% 7,69% 9.010
25/07/2006 44,84 46,50 44,00 45,80 +0,66% 5,58% 6.060
24/07/2006 48,30 48,90 45,50 45,50 -5,41% 7,04% 4.160
21/07/2006 49,90 50,60 47,10 48,10 -3,61% 7,01% 2.820
20/07/2006 50,70 50,70 47,80 49,90 +1,84% 5,72% 8.600
19/07/2006 47,90 49,00 47,20 49,00 +6,52% 3,76% 6.360
18/07/2006 44,70 47,70 44,00 46,00 +3,14% 8,28% 6.490
17/07/2006 47,30 47,40 44,10 44,60 -4,90% 6,98% 6.430
14/07/2006 45,60 48,40 45,10 46,90 -1,26% 7,24% 5.480
13/07/2006 49,40 49,60 47,00 47,50 -3,46% 5,26% 7.090
12/07/2006 50,10 50,20 49,00 49,20 -2,19% 2,40% 1.470
11/07/2006 51,00 51,00 49,80 50,30 +0,60% 2,35% 2.410
10/07/2006 50,50 51,00 48,90 50,00 -0,79% 4,16% 1.530
07/07/2006 53,00 53,00 45,00 50,40 -1,95% 15,09% 8.680
06/07/2006 53,00 53,20 50,30 51,40 -3,38% 5,47% 2.710
05/07/2006 52,90 54,00 50,40 53,20 +0,38% 6,81% 7.030
03/07/2006 51,40 53,00 51,00 53,00 +4,33% 3,89% 2.380
30/06/2006 50,40 51,40 50,00 50,80 +0,40% 2,78% 4.950
29/06/2006 48,40 51,40 48,40 50,60 +4,33% 6,20% 7.930
28/06/2006 50,90 50,90 45,70 48,50 -0,41% 10,22% 10.340
27/06/2006 51,60 51,70 48,20 48,70 -4,88% 6,78% 2.550
26/06/2006 49,50 51,80 48,70 51,20 +7,02% 6,26% 3.370
23/06/2006 48,60 48,70 47,80 47,84 -3,35% 1,85% 2.280
22/06/2006 50,10 50,30 48,63 49,50 -0,20% 3,33% 2.620
21/06/2006 50,00 50,50 48,80 49,60 +1,85% 3,40% 12.260
20/06/2006 45,00 49,50 45,00 48,70 +7,74% 10,00% 7.440
19/06/2006 47,70 48,10 45,10 45,20 -5,44% 6,29% 2.790
16/06/2006 46,80 48,10 45,90 47,80 +2,58% 4,70% 6.940